ANGELA LOWE: Open Payments
NPI 1811367360 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,451 in 205 payments from 22 companies in 2025. Trend: 2023 $1,606 · 2024 $2,509 · 2025 $3,451
Food & beverage: $3,431Education: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $830 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 50 | $755 |
| Ardelyx, Inc. | 28 | $355 |
| Phathom Pharmaceuticals, Inc. | 29 | $318 |
| Janssen Biotech, Inc. | 14 | $261 |
| Madrigal Pharmaceuticals | 6 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $159 |
| Ipsen Biopharmaceuticals, Inc | 8 | $137 |
| QOL Medical, LLC | 4 | $102 |
| GENZYME CORPORATION | 4 | $77 |
Products named: XIFAXAN, IBSRELA, VOQUEZNA, TREMFYA, RINVOQ, SKYRIZI, CREON, REZDIFFRA.
Industry payments across KY — which companies pay providers there.
